• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

What keeps you up at night in ophthalmology: Part VI

Video

Ophthalmologists and industry executives share what lingers on their minds at the end of the day.

Featured in this video, in order of appearance:

Jag Dosanjh; senior vice president, Eye Care (Allergan, an AbbVie company)

Mitch Shultz, MD; Shultz Chang Vision (Northridge, CA)

Yolande Barnard; vice president, general manager, U.S. Pharmaceuticals (Bausch + Lomb)

Eric Donnenfeld, MD; Ophthalmic Consultants of Long Island (Garden City, NY)

Edward Manche, MD; Stanford University School of Medicine (Palo Alto, CA)



Watch the previous installments in this series:

What keeps you up at night in ophthalmology?

What keeps you up at night in ophthalmology: Part II

What keeps ophthalmologists up at night: Part III

What keeps ophthalmologists up at night: Part IV

What keeps you up at night in ophthalmology: Part V

Related Videos
© 2024 MJH Life Sciences

All rights reserved.